Articleposted 2025-12-22 09:19:47
Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: single-arm, open-label, phase I study
Kai Hu, Fan Yang, Rui Liu, Zhonghua Fu, Yuelu Guo, Lixia Ma, Miaomiao Cao, and 6 more authors
Under Review
at
Articleposted 2025-12-22 08:53:05
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients
Naseema Gangat, Saubia Fathima, Lior Rokach, Nour Ghosoun, Mahsa Rezasoltani, Rimal Ilyas, Ali Alsugair, and 23 more authors
Under Review
at
Articleposted 2025-11-13 14:50:26
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response
Ethel Cesarman, Mikhail Roshal, Isabella Kong, Wikum Dinalankara, Jonathan Reichel, Matthew Teater, Bhavneet Binder, and 14 more authors
Under Review
at
Articleposted 2025-10-29 04:13:01
ZMYM3 mutations modulate histone acetylation and cooperate with NOTCH1 mutations in chronic lymphocytic leukemia
Miguel Quijada-Álamo, Alberto Rodríguez-Sánchez, Claudia Pérez-Carretero, Luis Antonio Corchete Sánchez, Cristina Miguel-García, Sandra Santos-Mínguez, Ángela Villaverde-Ramiro, and 6 more authors
Under Revision
at
Articleposted 2025-09-30 12:22:54
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study
Matthew Hamby, Brian Egleston, Zachary Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal, Emeline Chong, and 40 more authors
Under Review
at
Articleposted 2025-08-22 06:33:15
Intensive Chemotherapy with or without Midostaurin in Adults ≥60 years old with FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study
Gaspar Aspas Requena, Pau Montesinos, Emilie BERARD, Sarah Bertoli, Rebeca Rodriguez-Veiga, Célestine Simand, Laura Torres-Miñana, and 25 more authors
Under Revision
at
Articleposted 2025-07-31 10:26:31
Outcomes of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma by Race: A Multicenter Real-World Study
Manisha Bhutani, Hira Shaikh, Alma Habib, Andrew vegel, Ami Ndiaye, Emily Struble, Darryl Chang, and 10 more authors
Published
at
Articleposted 2025-07-10 12:47:58
Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study
Thomas Chalopin, Elise Cellerin, Hélène Demarquette, andrea pieragostini, Cecile Sonntag, Caroline Jacquet, Zoe van de Wyngaert, and 12 more authors
Published
at
Articleposted 2025-06-16 15:07:51
Synthetic control arm from mixed clinical trials and real-world data from LYSA group for untreated diffuse large B cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials
Benoit Tessoulin, Valentin LETAILLEUR, Isabelle Chaillol, Fanny Cherblanc, Hervé Ghesquières, Frédéric Peyrade, Stéphanie Guidez, and 10 more authors
Published
at
Articleposted 2025-06-09 11:23:25
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients
Ayalew Tefferi, Ali Alsugair, Estefania Gauto-Mariotti, Mohammad Alhousani, Saubia Fathima, Muhammad Yousuf, Abiola Bolarinwa, and 20 more authors
Published
at